FDA.reportPublic FDA data

bismuth subsalicylate 262 MG Oral Capsule [Pepto-bismol]

RxCUI
2121074
RxNorm name
bismuth subsalicylate 262 MG Oral Capsule [Pepto-bismol]
Display name
PEPTO-BISMOL (Oral Pill)
Full name
bismuth subsalicylate 262 MG Oral Capsule [Pepto-bismol]
Term type
SBD
Status
Active
Strength
262 mg
Dose form
Cap
Route
Oral Pill
Updated
2026-11-14 08:22:09

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
052019
Active start
052019
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
bismuth subsalicylate262 MG / 1 EACHbismuth subsalicylatebismuth subsalicylate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Capsule316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bismuth subsalicylate19478

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRPepto-bismol 262 MG Oral Capsule1NAMES
RxNorm Namebismuth subsalicylate 262 MG Oral Capsule [Pepto-bismol]1NAMES
RxNorm SynonymPepto-bismol 262 MG Oral Capsule1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID84ffa6d6-03e1-59e8-e053-2a91aa0afd6e1CODES
RxCUI21210741CODES
MMSL_CODEBD377311CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
37000-535-1237000-535Pepto Bismol Bismuth subsalicylateThe Procter & Gamble Manufacturing CompanyM008
37000-535-2437000-535Pepto Bismol Bismuth subsalicylateThe Procter & Gamble Manufacturing CompanyM008
37000-535-4837000-535Pepto Bismol Bismuth subsalicylateThe Procter & Gamble Manufacturing CompanyM008

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M00837000-535Pepto Bismol Bismuth subsalicylateOTC MONOGRAPH DRUGThe Procter & Gamble Manufacturing Company

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 7 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00149000173rxnav_ndcsyes
37000053512rxnav_ndcsyes
37000053524rxnav_ndcsyes
37000053548rxnav_ndcsyes
37000053748rxnav_ndcsyes
37000053712rxnav_historical
37000053724rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
84ffa6d6-03e1-59e8-e053-2a91aa0afd6ePepto-Bismol 262 MG Oral Capsule [PSN] · bismuth subsalicylate 262 MG Oral Capsule [Pepto-bismol] [SBD] · Pepto-bismol 262 MG Oral Capsule [SY]312Pepto Bismol ® LiquiCaps20260423
851997d7-cb82-17bf-e053-2a91aa0ab78bPepto-Bismol 262 MG Oral Capsule [PSN] · bismuth subsalicylate 262 MG Oral Capsule [Pepto-bismol] [SBD] · Pepto-bismol 262 MG Oral Capsule [SY]310Pepto Bismol ® Diarrhea LiquiCaps20231128

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
84ffa6d6-03e1-59e8-e053-2a91aa0afd6ePepto Bismol ® LiquiCapsThe Procter & Gamble Manufacturing Company20261005
84ffa6d6-03e1-59e8-e053-2a91aa0afd6ePepto Bismol ® LiquiCapsThe Procter & Gamble Manufacturing Company20260423
84ffa6d6-03e1-59e8-e053-2a91aa0afd6ePepto Bismol ® LiquiCapsThe Procter & Gamble Manufacturing Company20251001
851997d7-cb82-17bf-e053-2a91aa0ab78bPepto Bismol ® Diarrhea LiquiCapsThe Procter & Gamble Manufacturing Company20231128

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
FDASPLD001729BismuthCHEMhas_chemical_structurebismuth subsalicylate
FDASPLN0000180183BismuthEPChas_epcbismuth subsalicylate
MEDRTD001729BismuthCHEMhas_ingredientbismuth subsalicylate
MEDRTD009942Organometallic CompoundsCHEMhas_ingredientbismuth subsalicylate
MEDRTD012459SalicylatesCHEMhas_ingredientbismuth subsalicylate
MEDRTD001778Blood Coagulation DisordersDISEASEci_withbismuth subsalicylate
MEDRTD002644ChickenpoxDISEASEci_withbismuth subsalicylate
MEDRTD003967DiarrheaDISEASEmay_treatbismuth subsalicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withbismuth subsalicylate
MEDRTD004405Dysentery, BacillaryDISEASEmay_treatbismuth subsalicylate
MEDRTD004415DyspepsiaDISEASEmay_treatbismuth subsalicylate
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatbismuth subsalicylate
MEDRTD006471Gastrointestinal HemorrhageDISEASEci_withbismuth subsalicylate
MEDRTD016481Helicobacter InfectionsDISEASEmay_treatbismuth subsalicylate
MEDRTD009325NauseaDISEASEmay_treatbismuth subsalicylate
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withbismuth subsalicylate
MEDRTD013272Stomach DiseasesDISEASEmay_treatbismuth subsalicylate
MEDRTD014777Virus DiseasesDISEASEmay_treatbismuth subsalicylate
MEDRTN0000000226Acid-Base ActivityMOAhas_moabismuth subsalicylate
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moabismuth subsalicylate
MEDRTN0000009724Inhibition Gastric Acid SecretionPEhas_pebismuth subsalicylate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH262 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
NAMESPrescribable SynonymPepto-Bismol 262 MG Oral Capsule
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon